$0.0779
At close: Oct 13, 5:00 PM EST
Comments
Loading...
Navidea Biopharmaceuticals Inc Earnings Estimates, EPS & Revenue | OTC:NAVB | Benzinga
Navidea Biopharmaceuticals Inc reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.020
Quarterly Revenue
$0.00
Annual Revenue
–
Analyze the earnings history of Navidea Biopharmaceuticals Inc using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
NAVB | Navidea Biopharmaceutical | -$0.25 | — | -$0.02 | — | $7.52K | — | $0.00 | — | 11/14/2023 | |
NAVB | Navidea Biopharmaceutical | -$0.10 | — | -$0.03 | — | $57.53K | — | $0.00 | — | 08/11/2023 | |
NAVB | Navidea Biopharmaceutical | -$0.10 | — | -$0.09 | — | $0.00 | — | $0.00 | — | 05/11/2023 | |
NAVB | Navidea Biopharmaceutical | -$0.12 | — | -$0.11 | — | $50.35K | — | $610.00 | — | 03/21/2023 | |
NAVB | Navidea Biopharmaceutical | -$0.08 | — | -$0.25 | — | $96.38K | — | $7.52K | — | 11/14/2022 | |
NAVB | Navidea Biopharmaceutical | -$0.09 | — | -$0.10 | — | $261.05K | — | $57.53K | — | 08/15/2022 | |
NAVB | Navidea Biopharmaceutical | -$0.11 | — | -$0.10 | — | $123.74K | — | $0.00 | — | 05/12/2022 | |
NAVB | Navidea Biopharmaceutical | -$0.11 | — | -$0.12 | — | $219.25K | — | $50.35K | — | 03/23/2022 | |
NAVB | Navidea Biopharmaceutical | -$0.13 | -$0.11 | -$0.08 | 27.27% | $268.39K | — | $96.38K | — | 11/10/2021 | |
NAVB | Navidea Biopharmaceutical | -$0.11 | -$0.08 | -$0.09 | -12.50% | $271.10K | — | $261.05K | — | 08/11/2021 | |
NAVB | Navidea Biopharmaceutical | -$0.13 | -$0.08 | -$0.12 | -50.00% | $156.27K | — | $123.74K | — | 05/11/2021 | |
NAVB | Navidea Biopharmaceutical | -$0.15 | -$0.12 | -$0.11 | 8.33% | $119.30K | $600.00K | $219.25K | -63.46% | 03/24/2021 |
Navidea Biopharmaceuticals Inc (NAVB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2021-11-10 | $-0.08 | $-0.11 | 27.3 % |
| Q2 | 2021-08-11 | $-0.09 | $-0.08 | -12.5 % |
| Q1 | 2021-05-11 | $-0.12 | $-0.08 | -50.0 % |
| Q4 | 2021-03-24 | $-0.11 | $-0.12 | 8.33 % |
Navidea Biopharmaceuticals Inc (NAVB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2021-03-24 | $219.25K | $600.00K | -63.5 % |
FAQ
When is Navidea Biopharmaceuticals Inc (OTC:NAVB) reporting earnings?
Navidea Biopharmaceuticals Inc (NAVB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3.
What were the latest earnings per share (EPS) for Navidea Biopharmaceuticals Inc (OTC:NAVB)?
Navidea Biopharmaceuticals Inc (NAVB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3 and the Actual EPS was $-0.02, which missed the estimate of $0.00.
What were Navidea Biopharmaceuticals Inc’s (OTC:NAVB) revenues?
Navidea Biopharmaceuticals Inc (NAVB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3 and the Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
